Patent details

EP1448235 Title: ORAL CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS OF 5,8,14-TRIAZATETRACYCLO 10.3.1.0(2,11).0(4,9)Ü-HEXADECA-2(11)3,5,7,9-PENTAENE

Basic Information

Publication number:
EP1448235
PCT Application Number:
PCT/IB/2002/004612
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP027857184
PCT Publication Number:
WO/2003/045437
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ORAL CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS OF 5,8,14-TRIAZATETRACYCLO 10.3.1.0(2,11).0(4,9)Ü-HEXADECA-2(11)3,5,7,9-PENTAENE
French Title of Invention:
COMPOSITIONS PHARMACEUTIQUES A LIBERATION PROLONGEE DE 5,8,14-TRIAZATETRACYCLO 10.3.1.0(2,11).0(4,9)Ü-HEXADECA-2(11)3,5,7,9-PENTAENE
German Title of Invention:
ORALE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN MIT VERZÖGERTER FREISETZUNG ENTHALTEND 5,8,14-TRIAZATETRACYCLO (10.3.1.0(2,11) 0 (4,9) )-HEXADECA-2(11) 3, 5,7, 9-PENTAENE
SPC Number:

Dates

Filing date:
04/11/2002
Grant date:
14/03/2007
EP Publication Date:
14/03/2007
PCT Publication Date:
05/06/2003
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
25/08/2004
EP B1 Publication Date:
14/03/2007
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
04/11/2012
Expiration date:
04/11/2022
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
04/11/2002
 
 

Name:
Pfizer Products Inc.
Address:
Eastern Point Road, Groton, Connecticut 06340, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
14/03/2007
Address:
PO Box 48, 8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
WATERMAN Kenneth Craig Pfizer Global Res. & Dev.
Address:
United States (US)

2

Name:
SMITH Scott Wendell Pfizer Global Res. & Dev.
Address:
United States (US)

3

Name:
ROY Michael Christopher
Address:
United States (US)

4

Name:
QUAN Ernest Shing Pfizer Global Res. & Dev.
Address:
United States (US)

5

Name:
AM ENDE Mary Tanya
Address:
United States (US)

6

Name:
MOSES Sara Kristen Pfizer Global Res. & Dev.
Address:
United States (US)

Priority

Priority Number:
334652 P
Priority Date:
30/11/2001
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/4995;
Filing date Document type Number of pages